Logo.jpg
Memo Therapeutics increases Series C financing to CHF 45 million
May 07, 2024 02:00 ET | Memo Therapeutics AG
PRESS RELEASE Memo Therapeutics increases Series C financing to CHF 45 million Additional CHF 20 million raised from new investors Ysios Capital and Kurma Partners as well as from existing...